A team of scientists including UCL researchers has tested four anti-amyloid Alzheimer's therapeutics to find out how the drugs bind to toxic amyloid beta protein to tackle the disease.

A team of scientists, including researchers from University College London (UCL), has discovered key differences in how four ...

The causes of Alzheimer’s disease have long puzzled researchers, especially when most older adults show signs of the illness ...

Researchers have developed a tau-targeting vaccine that could help prevent the progression of Alzheimer’s disease by ...

Researchers have developed engineered human microglia that detect disease-related brain changes and release therapeutic ...

There's still so much we don't know about Alzheimer's disease, but the link between poor sleep and worsening disease is one ...

NU-9 targets a shared underlying mechanism found in various neurodegenerative diseases. A new study from Northwestern University reports that NU-9, an experimental small-molecule drug currently ...

Quest Diagnostics has introduced a new blood test aimed at assisting physicians in confirming amyloid brain pathology related ...

Learn about the impact of Alzheimer's family history on brain resilience and memory function. Your family tree may shape your ...

Not surprisingly, finding the magic bullet has become the holy grail for Alzheimer’s researchers. But it’s proving to be an ...

A commonly prescribed sleeping pill could be a powerful tool in preventing Alzheimer's disease, according to recently ...